HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elisa Pagnin Selected Research
Elisa Pagnin Research Topics
Disease
15
Hypertension (High Blood Pressure)
02/2023 - 10/2002
9
Gitelman Syndrome
08/2018 - 01/2003
6
Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 01/2003
6
Cardiovascular Diseases (Cardiovascular Disease)
06/2014 - 02/2006
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 10/2015
4
Hypotension (Low Blood Pressure)
02/2014 - 01/2003
3
Fibrosis (Cirrhosis)
01/2016 - 04/2004
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2015 - 02/2011
3
Atherosclerosis
12/2011 - 10/2004
3
Inflammation (Inflammations)
02/2011 - 06/2006
2
Disease Progression
10/2023 - 01/2003
2
Neoplasms (Cancer)
10/2021 - 01/2016
2
Atrial Fibrillation
01/2020 - 01/2019
2
Chronic Renal Insufficiency
01/2019 - 03/2016
2
Fabry Disease (Fabry's Disease)
11/2018 - 01/2018
2
Type 2 Diabetes Mellitus (MODY)
04/2016 - 04/2003
2
Hypertrophy
03/2016 - 06/2014
2
Insulin Resistance
10/2015 - 10/2013
2
Heart Failure
03/2015 - 03/2008
2
Rare Diseases (Rare Disease)
10/2013 - 07/2012
2
Vascular Remodeling
12/2011 - 02/2011
1
Alkalosis
02/2023
1
Lymphoid Leukemia
10/2021
1
Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2018
1
Large Granular Lymphocytic Leukemia
09/2017
1
Neutropenia
09/2017
1
Diabetic Nephropathies (Diabetic Nephropathy)
04/2016
1
Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2016
1
Obesity
10/2015
1
Body Weight (Weight, Body)
10/2015
1
Lung Diseases (Lung Disease)
03/2015
1
Coronary Disease (Coronary Heart Disease)
03/2015
1
Bartter Syndrome (Syndrome, Bartter)
02/2014
Drug/Important Bio-Agent (IBA)
12
Angiotensin II
IBA
01/2016 - 01/2003
10
Proteins (Proteins, Gene)
FDA Link
01/2016 - 09/2005
9
rho-Associated Kinases
IBA
01/2020 - 10/2004
5
4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)
IBA
06/2014 - 04/2003
4
Cytokines
IBA
01/2018 - 06/2006
4
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2018 - 10/2002
4
Heme Oxygenase-1
IBA
04/2016 - 07/2006
3
Enzymes
IBA
11/2018 - 09/2010
3
oxidized low density lipoprotein
IBA
06/2014 - 02/2011
3
NADPH Oxidases (NAD(P)H oxidase)
IBA
09/2008 - 04/2003
2
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
03/2024 - 10/2019
2
Vitamin E
FDA Link
Generic
01/2019 - 02/2011
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2015 - 02/2006
2
Glucose (Dextrose)
FDA Link
Generic
10/2015 - 09/2010
2
LDL Cholesterol
IBA
03/2015 - 02/2006
2
Type 1 Angiotensin Receptor
IBA
02/2014 - 10/2013
2
Messenger RNA (mRNA)
IBA
02/2014 - 09/2005
2
Heme Oxygenase (Decyclizing) (Heme Oxygenase)
IBA
01/2014 - 02/2011
2
Antioxidants
IBA
01/2014 - 12/2011
2
erucylphosphocholine
IBA
07/2012 - 09/2011
2
GTP-Binding Proteins (G-Protein)
IBA
05/2008 - 08/2004
2
C-Reactive Protein
IBA
06/2006 - 04/2006
2
Superoxides (Superoxide)
IBA
03/2005 - 04/2003
2
Aldosterone
IBA
04/2004 - 01/2003
1
Calpain
IBA
10/2023
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
10/2023
1
Cortactin
IBA
10/2023
1
Sodium
IBA
02/2023
1
Transcription Factors (Transcription Factor)
IBA
10/2021
1
ibrutinib
IBA
10/2021
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
10/2021
1
Gap Junction alpha-5 Protein
IBA
01/2020
1
HDL Lipoproteins
IBA
01/2019
1
Galactosidases
IBA
11/2018
1
globotriaosylceramide (globotriosylceramide)
IBA
11/2018
1
Sodium Chloride
FDA Link
Generic
08/2018
1
Symporters
IBA
08/2018
1
Fas Ligand Protein (Fas Ligand)
IBA
09/2017
1
Cadherins (E-Cadherin)
IBA
01/2016
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
01/2016
1
Endothelin-1 (Endothelin 1)
IBA
01/2016
1
NADPH Oxidase 4
IBA
12/2015
1
Oxygen (Dioxygen)
IBA
12/2015
1
Insulin (Novolin)
FDA Link
10/2015
1
Leptin
IBA
10/2015
1
HDL Cholesterol
IBA
03/2015
1
Lipids
IBA
03/2015
1
Adipokines
IBA
06/2014
1
Retinol-Binding Proteins (Retinoid Binding Proteins)
IBA
06/2014
1
Capsules (Microcapsules)
IBA
06/2014
1
Calcitonin Gene-Related Peptide
IBA
01/2014
1
Sirtuin 1
IBA
10/2013
1
Angiotensins
IBA
07/2012
1
Angiotensin II Type 1 Receptor Blockers
IBA
12/2011
1
olmesartan
IBA
12/2011
1
LDL Lipoproteins (beta Lipoproteins)
IBA
12/2011
1
Immunosorbents
IBA
02/2011
1
TOR Serine-Threonine Kinases
IBA
02/2011
1
Nitric Oxide Synthase (NO Synthase)
IBA
02/2011
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
02/2011
1
Bicarbonates (Hydrogen Carbonate)
IBA
02/2011
1
Plasminogen Inactivators
IBA
02/2011
Therapy/Procedure
3
Therapeutics
12/2023 - 09/2015
2
Renal Dialysis (Hemodialysis)
01/2019 - 02/2011
1
Enzyme Replacement Therapy
01/2018
1
Time-to-Treatment
10/2015
1
Hemodiafiltration
02/2011